This process generates anti-β-hydroxytryptophans using Ru-catalyzed asymmetric transfer hydrogenation and dynamic kinetic resolution.
A general approach to anti-β-hydroxytryptophans via the corresponding α-amino-β-keto esters through a Ru-catalyzed asymmetric transfer hydrogenation-dynamic kinetic resolution (ATH-DKR) cascade is described. The requisite starting materials are prepared through a robust, scalable, and chromatography-free three-step approach from indole-3-carboxylic acids. A thorough HTE screening/optimization of the ATH-DKR reaction, with regard to protecting groups and substitution patterns, was undertaken to prepare an array of analogs in very good yields and with high enantio- and diastereoselectivity.
No takes yet. Share an insight, caveat, or question.
Pollack et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: